| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.42B | 24.62B | 25.19B | 24.89B | 24.42B | 25.33B |
| Gross Profit | 3.56B | 3.58B | 3.83B | 3.90B | 3.81B | 4.43B |
| EBITDA | 168.00M | -125.00M | 686.00M | -638.00M | -89.00M | 389.00M |
| Net Income | -392.00M | -640.00M | 150.00M | -1.19B | -718.00M | -240.00M |
Balance Sheet | ||||||
| Total Assets | 12.28B | 12.52B | 13.57B | 13.71B | 14.45B | 15.85B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.87B | 2.68B | 2.32B | 2.35B | 2.63B |
| Total Debt | 5.61B | 5.84B | 5.97B | 6.33B | 6.03B | 6.36B |
| Total Liabilities | 10.34B | 10.67B | 11.20B | 11.48B | 11.00B | 11.51B |
| Stockholders Equity | 1.94B | 1.85B | 2.37B | 2.23B | 3.45B | 4.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -544.00M | -595.00M | -395.00M | -199.00M | 70.00M |
| Operating Cash Flow | 0.00 | -239.00M | -178.00M | -49.00M | 205.00M | 349.00M |
| Investing Cash Flow | 0.00 | -354.00M | 909.00M | -278.00M | -198.00M | -290.00M |
| Financing Cash Flow | 0.00 | -220.00M | -366.00M | 292.00M | -337.00M | 64.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €538.55B | 20.47 | 9.86% | 2.58% | 1.08% | 2.71% | |
67 Neutral | ¥60.52B | 12.24 | 6.48% | 2.27% | 1.46% | ― | |
64 Neutral | ¥341.93B | 21.77 | ― | 2.61% | 6.54% | 15.08% | |
63 Neutral | ¥703.40B | 22.54 | 6.04% | 2.04% | 5.55% | 27.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | ¥6.13B | -35.43 | ― | ― | -3.27% | -108.33% | |
37 Underperform | ¥2.09B | -4.68 | ― | ― | -2.97% | -6.82% |